National Center for Advancing Translational Sciences in New York
National Center for Advancing Translational Sciences (93.350) awarded $351 million to recipients in New York in 73 grants from fiscal 2021 to 2025, 11% of the program's national total. New York University received the most, $66.9 million.
- Awarded in New York$351 million
- Awards73
- Share of the program11%
- Rank among states2nd of 41
- National total$3.1 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 39 | $82.1 million |
| FY 2022 | 35 | $70.3 million |
| FY 2023 | 39 | $69.9 million |
| FY 2024 | 40 | $65.0 million |
| FY 2025 | 29 | $63.6 million |
Recipients in New York
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| New York University | Colleges and universities | 5 | $66.9 million |
| The Trustees of Columbia University in the City of New York | Colleges and universities | 9 | $66.5 million |
| Icahn School of Medicine at Mount Sinai | Colleges and universities | 10 | $57.1 million |
| Weill Medical College of Cornell University | Colleges and universities | 5 | $55.9 million |
| University of Rochester | Colleges and universities | 11 | $28.6 million |
| Albert Einstein College of Medicine, Inc. | Colleges and universities | 8 | $23.8 million |
| The Rockefeller University | Colleges and universities | 3 | $23.6 million |
| The Research Foundation for the State University of New York | Other | 7 | $22.6 million |
| Hastings Center Inc | Nonprofits | 1 | $1.9 million |
| Spheryx, Inc. | Small businesses | 1 | $996,838 |
Open opportunities under this program
- Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
- Limited Competition: NCATS Clinical and Translational Science Award (CTSA) Program Research Education Grants Programs (R25 - Clinical Trial Not Allowed)
- Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
- Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
- NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
- Clinical and Translational Science Award (UM1 Clinical Trial Optional)
- Limited Competition: Mentored Research Career Development Program Award in Clinical and Translational Science Awards (CTSA) Program (K12 Clinical Trial Optional)
See all 34 on the program page
Questions people ask
How much National Center for Advancing Translational Sciences money goes to New York?
$351 million from fiscal 2021 to 2025, across 73 awards. New York ranks 2nd of 41 states and territories for this program.
Who receives National Center for Advancing Translational Sciences money in New York?
The largest recipient is New York University, with $66.9 million in 5 awards. Next are The Trustees of Columbia University in the City of New York and Icahn School of Medicine at Mount Sinai.
Can organizations in New York apply now?
Yes, 34 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
National Center for Advancing Translational Sciences in other states
Other large programs in New York
- Grants to States for Medicaid
- 1332 State Innovation Waivers
- Federal Transit Formula Grants
- Education Stabilization Fund
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Temporary Assistance for Needy Families
- Highway Planning and Construction
- National School Lunch Program
- Children's Health Insurance Program
- Public Housing Operating Fund